280 related articles for article (PubMed ID: 32354749)
1. Distinguishing neurosarcoidosis from multiple sclerosis based on CSF analysis: A retrospective study.
Arun T; Pattison L; Palace J
Neurology; 2020 Jun; 94(24):e2545-e2554. PubMed ID: 32354749
[TBL] [Abstract][Full Text] [Related]
2. CSF-ACE activity in probable CNS neurosarcoidosis.
Tahmoush AJ; Amir MS; Connor WW; Farry JK; Didato S; Ulhoa-Cintra A; Vasas JM; Schwartzman RJ; Israel HL; Patrick H
Sarcoidosis Vasc Diffuse Lung Dis; 2002 Oct; 19(3):191-7. PubMed ID: 12405488
[TBL] [Abstract][Full Text] [Related]
3. Neurosarcoidosis: correlation of cerebrospinal fluid findings with diffuse leptomeningeal gadolinium enhancement on MRI and clinical disease activity.
Wengert O; Rothenfusser-Korber E; Vollrath B; Bohner G; Scheibe F; Otto C; Hofmann J; Angstwurm K; Ruprecht K
J Neurol Sci; 2013 Dec; 335(1-2):124-30. PubMed ID: 24071064
[TBL] [Abstract][Full Text] [Related]
4. Analysis of soluble interleukin-2 receptor as CSF biomarker for neurosarcoidosis.
Otto C; Wengert O; Unterwalder N; Meisel C; Ruprecht K
Neurol Neuroimmunol Neuroinflamm; 2020 Jul; 7(4):. PubMed ID: 32393650
[TBL] [Abstract][Full Text] [Related]
5. Leukocyte profiles in blood and CSF distinguish neurosarcoidosis from multiple sclerosis.
Heming M; Lohmann L; Schulte-Mecklenbeck A; Brix T; Gross CC; Wiendl H; Klotz L; Meyer Zu Hörste G
J Neuroimmunol; 2020 Apr; 341():577171. PubMed ID: 32007787
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid angiotensin-converting enzyme for diagnosis of neurosarcoidosis.
Bridel C; Courvoisier DS; Vuilleumier N; Lalive PH
J Neuroimmunol; 2015 Aug; 285():1-3. PubMed ID: 26198911
[TBL] [Abstract][Full Text] [Related]
7. Pattern II and pattern III MS are entities distinct from pattern I MS: evidence from cerebrospinal fluid analysis.
Jarius S; König FB; Metz I; Ruprecht K; Paul F; Brück W; Wildemann B
J Neuroinflammation; 2017 Aug; 14(1):171. PubMed ID: 28851393
[TBL] [Abstract][Full Text] [Related]
8. Neurosarcoidosis. Clinical description of 7 cases with a proposal for a new diagnostic strategy.
Marangoni S; Argentiero V; Tavolato B
J Neurol; 2006 Apr; 253(4):488-95. PubMed ID: 16283095
[TBL] [Abstract][Full Text] [Related]
9. Clinical features of spinal cord sarcoidosis: analysis of 17 neurosarcoidosis patients.
Sakushima K; Yabe I; Nakano F; Yoshida K; Tajima Y; Houzen H; Maruo Y; Sasaki H
J Neurol; 2011 Dec; 258(12):2163-7. PubMed ID: 21553080
[TBL] [Abstract][Full Text] [Related]
10. [Findings of cerebrospinal fluid in the diagnosis of multiple sclerosis].
Drulović J; Stojsavljević N; Dujmović I; Sokić D; Mavra M; Lević Z
Srp Arh Celok Lek; 1995; 123(7-8):191-3. PubMed ID: 17974427
[TBL] [Abstract][Full Text] [Related]
11. Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness.
Link H; Huang YM
J Neuroimmunol; 2006 Nov; 180(1-2):17-28. PubMed ID: 16945427
[TBL] [Abstract][Full Text] [Related]
12. [Angiotensin I-converting enzyme in cerebrospinal fluid and neurosarcoidosis].
Baudin B; Bénéteau-Burnat B; Vaubourdolle M
Ann Biol Clin (Paris); 2005; 63(5):475-80. PubMed ID: 16230281
[TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal fluid angiotensin converting enzyme levels in the diagnosis of neurosarcoidosis.
Jones DB; Mitchell D; Horn DB; Edwards CR
Scott Med J; 1991 Oct; 36(5):144-5. PubMed ID: 1664971
[TBL] [Abstract][Full Text] [Related]
14. The cerebrospinal fluid CD4/CD8 ratio and interleukin-6 and -10 levels in neurosarcoidosis: a multicenter, pragmatic, comparative study.
Chazal T; Costopoulos M; Maillart E; Fleury C; Psimaras D; Legendre P; Pineton de Chambrun M; Haroche J; Lubetzki C; Amoura Z; Legarff-Tavernier M; Cohen Aubart F
Eur J Neurol; 2019 Oct; 26(10):1274-1280. PubMed ID: 31021023
[TBL] [Abstract][Full Text] [Related]
15. Agarose electrophoresis and immunonephelometric quantitation of cerebrospinal fluid immunoglobulins: criteria for application in the diagnosis of neurologic disease.
Pearl GS; Check IJ; Hunter RL
Am J Clin Pathol; 1984 May; 81(5):575-80. PubMed ID: 6720628
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal ultra-extensive transverse myelitis as a manifestation of neurosarcoidosis.
Wang L; Li Y
J Neurol Sci; 2015 Aug; 355(1-2):64-7. PubMed ID: 26027786
[TBL] [Abstract][Full Text] [Related]
17. Neurosarcoidosis: clinical experience and diagnostic pitfalls.
Kellinghaus C; Schilling M; Lüdemann P
Eur Neurol; 2004; 51(2):84-8. PubMed ID: 14752214
[TBL] [Abstract][Full Text] [Related]
18. A multicenter study on the diagnostic significance of a single cerebrospinal fluid IgG band.
Ferraro D; Franciotta D; Bedin R; Solaro C; Cocco E; Santangelo M; Immovilli P; Gajofatto A; Calabrese M; Di Filippo M; Orlandi R; Simone AM; Vitetta F; Capello E; Giunti D; Murialdo A; Frau J; Mariotto S; Gallina A; Gasperini C; Sola P;
J Neurol; 2017 May; 264(5):973-978. PubMed ID: 28382419
[TBL] [Abstract][Full Text] [Related]
19. The complex relationship between oligoclonal bands, lymphocytes in the cerebrospinal fluid, and immunoglobulin G antibodies in multiple sclerosis: Indication of serum contribution.
Beseler C; Vollmer T; Graner M; Yu X
PLoS One; 2017; 12(10):e0186842. PubMed ID: 29059249
[TBL] [Abstract][Full Text] [Related]
20. Baló's concentric sclerosis is immunologically distinct from multiple sclerosis: results from retrospective analysis of almost 150 lumbar punctures.
Jarius S; Würthwein C; Behrens JR; Wanner J; Haas J; Paul F; Wildemann B
J Neuroinflammation; 2018 Jan; 15(1):22. PubMed ID: 29347989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
